Learn More
CERILLIANT™ 5beta/6beta-Hydroxy Lurasidone Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco H1251ML
Description
Hydroxylurasidone is the most abundant metabolite of lurasidone in urine. Lurasidone, marketed under the trade name Latuda™, is a new atypical antipsychotic developed for the treatment of schizophrenia and episodes of depression in adults with bipolar disorder (manic depression). A certified solution standard suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, pharmaceutical research, or urine drug testing.
Specifications
| 67-56-1 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 508.68 | |
| 1 mL |
| C28H36N4O3S | |
| 1.0 mg/mL in methanol | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation